Reverse Rett Singapore

We are beyond excited for this year’s Reverse Rett NYC. Your support of the event has never been more important. Our beneficiary, the Rett Syndrome Research Trust, has launched a bold $40 million initiative, Roadmap to Cures, that will select and develop three genetic medicines that attack the root cause of this devastating disorder. The goal is to advance these genetic medicines to clinical trials. This is in addition to the remarkable progress that RSRT has led in gene therapy, an approach that now has multiple clinical trials underway. Our cause is so urgent and so promising, and we can’t thank you enough for supporting as generously as you possibly can to help change 350,000 lives.